The present study was undertaken to determine the tissue-specific expression of estrogen receptor beta (ER ), and the effects of a daidzein supplement to the diet of pregnant sows on the expression of ER , and type 1 insulin-like growth factor receptor (IGF-1R) genes in newborn piglets by using semi-quantitative RT-PCR. Eight sows received a dietary supplement of daidzein at a dosage of 8 mg per kg feed from day 85 of gestation, and six sows were used as controls. After parturition, 2 male neonatal piglets were selected from each litter for sampling. ER mRNA was detected in intestine, lung, thymus, kidney, pituitary and hypothalamus tissues, but not in heart, adrenal, skeletal muscle, liver or placental tissues. Daidzein treatment significantly increased the birth weight of male piglets and markedly reduced the level of ER mRNA in the hypothalamus, but not in the pituitary. An up-regulation of IGF-1R gene transcription was observed in skeletal muscles of newborn piglets. In addition, the IGF-1R mRNA was found to be most abundant in pituitary and hypothalamus, followed by skeletal muscle, thymus, and liver tissues in decreasing order. Our results demonstrate that (1) ER is expressed in a tissue-specific manner in newborn piglets, (2) daidzein down-regulates ER gene expression in the hypothalamus, possibly indicating central effects of daidzein, and (3) daidzein influences fetal growth associated with higher IGF-IR gene expression in skeletal muscle.
Introduction
Previous studies suggest that plant-derived phytoestrogens, especially isoflavones, are potentially therapeutic compounds for a range of estrogen-dependent diseases, such as breast cancer, menopausal symptoms, cardiovascular disease and osteoporosis (Anderson 1999 , Adlercreutz et al. 2000 . Isoflavones are structurally similar to mammalian endogenous estrogens (Setchell & Cassidy 1999) , and thus may act as estrogen agonists or antagonists (Setchell et al. 1998) . Recent studies suggest that isoflavones act mainly through binding to estrogen receptor beta (ER ) (Kuiper et al. 1998b , Casanova et al. 1999 , Makela et al. 1999 . ER is the second subtype estrogen receptor expressed not only in reproductive organs, but also in hypothalamus, pituitary gland, lung, and other tissues in rats and humans (Kuiper et al. 1996 , Enmark & Gustafsson 1999 . ER and ER have high homology in the DNA binding domain (>95% amino-acid identity), but the homology in the ligand binding domain is relatively low, about 55% (Gustafsson 1999) . These structural differences may contribute to the different characteristics in ligand binding affinities, as well as in biological functions (Kuiper et al. 1997) . It was suggested that ER plays important roles in brain function (Gustafsson 1999 ) mediating estrogen in brain development during embryogenesis (Toran-Allerand 1999) . However, whether ER is expressed in porcine brain or other tissues is still unclear.
Daidzein, an aglycone, is an isoflavone present in large quantities in soybeans and other legumes. Recently, Liu et al. (1999) demonstrated that feeding pregnant sows with a daidzein-supplemented diet improved pre-and postnatal growth in newborn male piglets. However, the mechanisms mediating the effects of daidzein on animal growth are still unclear. Daidzein is a lipophilic substance with a molecular mass of 254 Da, thus it is able to pass through the placental barrier (Adlercreutz et al. 1999) . It was demonstrated that children in Asia are born with similar plasma levels of phytoestrogens as those of their mothers, indicating a free transfer of these compounds to the fetus. It is well known that insulin-like growth factor-I (IGF-I) and -II (IGF-II) play important roles in fetal growth, and they both exhibit growth promoting effects via the type 1 IGF receptor (IGF-1R) (Anthony et al. 1995 , Gluckman 1997 . Evidence exists that estrogen regulates expression of the IGF system in vitro and in vivo. In rhesus monkey uteri and human breast tissues, the IGF-I and IGF-1R mRNA levels have been shown to be up-regulated by estradiol (Adesanya et al. 1996 , Clarke et al. 1997 . It is therefore hypothesized that one of the mechanisms of the daidzein prenatal growth promoting effects might be by regulating the IGF-1R and ER at the level of gene transcription. In order to test our hypothesis, we used RT-PCR to investigate the distribution of ER in pig nonreproductive organs, and examined the effects of daidzein on the mRNA levels of the ER and IGF-1R gene in different tissues of newborn piglets.
Materials and Methods

Animals and feeding
All animals were cared for according to guidelines set by the Animal Protection Committee from the Ministry for Agriculture and Nature Protection, Schwerin, Germany. Sixteen multiparity sows (German Landrace, Pig Breeding Association North/Eastern, Germany) were mated to one German Landrace boar. Sow pregnancy was confirmed at day 28 of gestation by ultrasound. Sows had live weights of 180 7 kg, backfat depths of 19 2 mm (Piglog 105, SFK Technology A/S, Herlev, Denmark) and parities of 3·0 0·3. Sows were divided into experimental (n=8) and control (n=8) groups with balanced weight, backfat depth and parity. However, during the experiment two control sows were excluded due to skeletal system illness and premature farrowing respectively. The sows were housed individually at the pig experimental station of the Research Institute, under controlled environmental conditions (19 C, 60-80% relative humidity). All sows were fed twice daily with the same commercial pregnancy diet (Denkavit, Trede & Pein GmbH & Co. KG, Itzehohe, Germany) containing 11·8 MJ metabolizable energy per kg dry matter and 14·0% crude protein. All animals had free access to water. Throughout pregnancy, sows were fed manually corresponding to the following schedule: a daily feed ration of 2·6 kg at the beginning of the pregnancy was increased gradually to 5 kg at the end of the pregnancy. This schedule guaranteed an enhanced nutritional supply to the sows during pregnancy. From day 85 of gestation until parturition the ration of the experimental sows was supplemented with 8 mg daidzein per kg feed. Live weights, backfat depths, and sow parities were not significantly different between the two groups at day 85 of gestation. To induce farrowing, on day 114 of pregnancy all sows were injected intramuscularly with 1 ml of a synthetic prostaglandin analog (cloprostenol, 75 mg/ml: AniMedica West, Chemische Produkte GmbH, Senden, Germany).
Sample collection
After sow parturition, body weight and sex of newborn piglets were recorded. Two male piglets with body weights close to the mean were selected from each litter. Within 6 h after birth, daidzein piglets (n=16) and control piglets (n=12), were anesthetized with 1 ml of a mixture (v:v=1:1) of ursotamin and combelen and were then killed. Brains were removed immediately from the skull and the pituitary glands were collected. Boundaries used for dissecting the hypothalamus were as follows: rostral edge of the optic chiasm, immediate rostral to the mamillary body, width of the optic chiasm. The thymus, liver, longissimus dorsi muscle, heart (ventricle), small intestine (ileum), lung, adrenal gland and kidney (cortex) were also collected. Additionally, after parturition fresh placental tissue (endometrium) was collected. All samples were immediately frozen in liquid nitrogen and stored at 70 C until RNA isolation.
RNA extraction, cDNA synthesis, and polymerase chain reaction
Total RNAs were isolated from tissue samples using the RNeasy mini kit (QIAGEN, Atsworth, CA, USA) according to the manufacturer's instructions. RNA yields and purities were assessed by absorbance at 260 and 280 nm in a RNA/DNA Calculator (Amersham Pharmacia Biotech Europe, Freiburg, Germany). Ratios of absorption (260/280 nm) of all preparations were between 1·8 and 2·0. Aliquots of RNA samples were subjected to electrophoresis to verify their integrity. The cDNA was synthesized using 1·0 µg total RNA from each sample. RNA samples were denatured at 65 C for 15 min and placed on ice for 5 min before reverse transcription (RT). The final reaction volume, 25 µl, contained 1 reaction buffer, 5 mM MgCl 2 , 1 mM dNTPs, 3·2 µg random primer p(dN) 6 , 50 units RNase inhibitor, 0·01 mg/ml gelatin and 20 units AMV reverse transcriptase (1st strand cDNA synthesis kit, Boehringer Mannheim Corp., Indianapolis, IN, USA). The reaction was performed at 25 C for 10 min, 42 C for 60 min, 99 C for 5 min for enzyme heat inactivation, and 4 C for 5 min. RT products were either stored at 20 C or used directly for PCR. To eliminate residual genomic DNA from the RNA sample, prior to the RT reaction, 1 unit DNaseI (Roche Diagnostics, Mannheim, Germany) was added and incubated at 37 C for 30 min followed by heat-inactivation of the enzyme at 75 C for 5 min (Huang et al. 1996) . Genomic DNA amplification contamination was checked periodically by control experiments in which reverse transcriptase (positive control) or RNA (negative control) were omitted during the RT step.
PCR was performed in a 50 µl reaction volume containing 2·0 µl tissue-specific cDNA (equivalent to 80 ng of starting RNA), 1·5 mM MgCl 2 , 2 units Taq DNA polymerase (Boehringer Mannheim GmbH, Mannheim, Germany), 0·2 mM dNTPs and 0·4 µM of each primer. For amplification of the target genes, the following primer pairs were used: ER (GeneBank accession no. AF164957) forward 5 -TCTCCTGTCTCCTACAACT GCA and reverse 5 -GGCATCCCTCTTTGAACTT GGA, for amplification of a 396-bp fragment of pig ER cDNA; IGF-1R (GeneBank accession no. AB003362) forward 5 -CCCAAAGTCTGTGAGGAAGAGA and reverse 5 -TTAGTCCCTGTCACTTCCTC-CA, for amplification of a 422-bp fragment of pig IGF-1R cDNA. Additional reactions were run using primers for -actin (GeneBank accession no. U07786) forward 5 -GGAGA TCGT GCGGGACATCAAG and reverse 5 -GGCGTA GAGGTCCTTCCTGATG, to serve as a control. These primers amplify a 269-bp fragment of pig -actin cDNA. To obtain optimal conditions for amplification, in the exponential phase of PCR the cycle numbers were tested first for each target gene. Plotting PCR signal intensity (as expressed by net intensity) against the number of amplification cycles revealed a strong linear relationship between cycles 32 and 40 for ER (correlation coefficient r 2 =0·996), and between cycles 24 and 32 (r 2 =0·983) for IGF-1R.
QuantumRNA 18S primer and competimer (Ambion, Inc. Austin, TX, USA) were used as internal controls of amplification. This primer pair (catalog no. 1716) amplifies a 488-bp fragment. The ratio of 18S primer to competimer was 1:9 for ER and IGF-1R genes. Amplifications were performed in a Biometra Personal Cycler (Biomedizinische Analytik GmbH, Göttingen, Germany). For ER the following cycle parameters were used: 120 s at 94 C, 36 cycles at 94 C for 40 s, 60 C for 50 s, 72 C for 40 s. For IGF-1R, we used 28 cycles at 94 C for 40 s, 57 C for 45 s, 72 C for 45 s. Each reaction was followed by 5 min at 72 C and continuous hold at 4 C. After amplification, 10 µl of each PCR product were analyzed by agarose gel electrophoresis (2%).
Quantitation of PCR products (image analysis)
Gels were stained with ethidium bromide and photographed with a 3-CCD color camera using an image analysis system (Quantimet 570, Leica Cambridge Ltd, Cambridge, UK). Net intensities of individual bands (same area) were measured using Kodak Digital Science 1D software (Eastman Kodak Company, Rochester, NY, USA). Ratios of net intensity of target genes to that of the internal control bands (QuantumRNA 18S) were calculated before statistical analysis. To minimize the between-assay error, samples from two groups were always processed in parallel.
Statistical analysis
All values are reported as means ... Data were analyzed by ANOVA (STATISTICA program V5·0, StatSoft Inc., Tulsa, OK, USA) using a mixed model. For piglet performance data, treatment and piglet gender were employed as fixed factors, sow as a random factor and litter size as a covariant factor. Tissue mRNA levels were processed with the same model including tissue as a fixed factor, without including gender. Means were compared by Tukey HSD (honest significant difference) unequal number multiple comparison test. Student's t-test was used in the analysis of unpaired data.
Results
Body weights of newborn piglets and percentage of survival
The birth weight of male piglets in the daidzein-treated group was significantly higher (P<0·05) than that of the control group. However, female piglets were not found to have different birth weights. Sows fed with daidzein had a higher (P<0·05) percentage of survival than that of control sows (Table 1) .
Tissue distribution of ER mRNA in newborn piglets
Using RT-PCR, ER mRNA was detected in intestine, lung, thymus, kidney, pituitary and hypothalamus, but not in heart, adrenal gland, skeletal muscle, liver or placental tissues. The highest expression of ER mRNA was found in the hypothalamus. This was followed closely by the pituitary and the kidney which expressed a moderate level of ER mRNA, while expression in intestine, lung and thymus tissues was quite low (Fig. 1) .
Effects of daidzein on ER mRNA levels in hypothalamus and pituitary tissues
Relative mRNA levels of ER in the hypothalamus and the pituitary were measured by semi-quantitative RT-PCR. Compared with the control group, ER mRNA levels in the hypothalamus were markedly reduced in the daidzein group (P<0·05) ( Fig. 2A,C) . However, in pituitary tissue no differences were found between the two groups ( Fig. 2B,C) . In the daidzein group, expression of ER mRNA was lower (P<0·05) in the hypothalamus compared with the pituitary, whereas in the control group there was no noticeable difference between these two tissues.
IGF-1R mRNA levels in newborn piglet tissues
The expression of IGF-1R in different tissues of newborn piglets in the daidzein and control groups is presented in Fig. 3 . Compared with the control group, relative muscle IGF-1R mRNA levels in the daidzein-fed group were significantly higher (P<0·05). IGF-1R mRNA levels in thymus and liver tissues increased in the daidzein group (P=0·08 and P=0·09 respectively), while no significant changes were detected in the hypothalamus or the pituitary. In addition, relative mRNA levels of IGF-1R gene were highest in the hypothalamus and pituitary, moderate in skeletal muscle and thymus, and were lowest in the liver.
Discussion
Since the discovery of the ER subtype by Kuiper et al. (1996) , many studies have shown that this receptor is expressed in multiple rat, mouse, and human tissues, in addition to the reproductive system tissues (Kuiper et al. 1998a , Casanova et al. 1999 . These discoveries have improved our knowledge of the mechanism of action of estrogen and its analogs. However, information about ER distribution in pigs is limited. Here, we have shown that there is ER mRNA expression in hypothalamus and pituitary tissues of newborn piglets. High amounts of ER transcripts were previously found in the pituitary of the pre-pubertal rat (Mitchner et al. 1998 , Wilson et al. 1998 , human (Shupnik et al. 1998) , and rhesus monkey (Pau et al. 1998) , whereas levels in mouse pituitary appeared to be low or nearly undetectable (Couse et al. 1997) . It has been reported that the expression of ER is high in rat and human fetal hearts (Saunders 1998) . In the present experiment we failed to detect ER mRNA in the heart of newborn piglets. Levels of ER expression in fetal human and rat kidneys are low or undetectable (Brandenberger et al. 1997 ), but we detected moderate expression in newborn piglets. ER signals detected in the thymus and the intestinal tract of newborn piglets were very weak; however very high expression in humans and rats has been reported (Enmark & Gustafsson 1999) . High expression has been reported in the adrenal gland of human fetuses (Brandenberger et al. 1997) . In our experiment, ER expression in the adrenal gland was not detected in newborn piglets which is in accord with results reported from prepubertal rats (Saunders 1998) . No ER transcripts have been found in rat or human livers (Enmark & Gustafsson 1999) . Using RT-PCR, mRNAs of ER in skeletal muscle, liver and placental tissue of newborn piglets were also undetectable in our experiment. Expression of the ER gene thus appears to be drastically different among tissues and species.
Since the hypothalamus and pituitary expressed the most abundant ER mRNA, we chose these two types of tissue to try and elucidate further the effects of daidzein. The results of ER expression in the pituitary are similar to those reported by Mitchner et al. (1998) who demonstrated that estradiol did not alter the expression of ER or ER in rat pituitaries. However, observations by Schreihofer et al. (2000) showed that ER mRNA levels fell 40% on the morning of proestrus and were suppressed by estradiol or dihydrotestosterone in ovariectomized female rat pituitaries. Schreihofer et al. (2000) also reported that progesterone or progesterone plus estradiol suppressed ER gene expression in rodent pituitary cell lines, yet the relative levels of ER mRNA in testes were increased after neonatal estrogen exposure (Tena-Sempere et al. 2000) . Very recently, it was found that daidzein is capable of significantly down-regulating the androgen receptor and the ER mRNA expression in rat uteri (Diel et al. 2000) . Data accumulated so far suggest that the effects of estrogen or its agonists on ER gene expression are tissue-specific and vary in different species. Our results demonstrate that daidzein regulates ER expression in a tissue-specific manner at the transcription level. The expression of ER in the hypothalamus was significantly down-regulated by daidzein, suggesting a direct effect of daidzein acting as an estrogen agonist on the hypothalamus-pituitary neuroendocrine functions. Dietary genistein exerted estrogenic effects upon the hypothalamic-pituitary axis in rats, increased plasma prolactin (Santell et al. 1997) , and enhanced growth hormone (GH) release in rat anterior pituitary cells (Ogiwara et al. 1997) . The serum levels of luteinizing hormone and prolactin in the pig were increased by supplemented daidzein feeding (Liu et al.1999) .
Both in vitro and in vivo experiments have shown that exogenous estrogens enhance cell (Lee et al. 1999) and tissue (Klotz et al. 2000) proliferation and growth. The growth promoting effect of exogenous estrogen in domestic animal production has been known for a long time (Lamming 1957) . The exact mechanism of this phenomenon is still unclear, but it is partially correlated with estrogen modulating growth-axis functions. Research indicates that exogenous estrogen augments serum concentrations of GH in cattle (Breier et al. 1988) and sheep (Phelps et al. 1988) , and of IGF-I in cattle (Coxam et al. 1990 ). Zeranol, a synthetic estrogen used for stimulating growth in domestic animals, was found to increase serum concentrations of IGF-I in lambs (Hufstedler et al. 1996) , and GH gene expression in pituitaries of wethers (Thomas et al. 2000) . Our results, together with previous findings (Liu et al. 1999) suggest that daidzein improves male fetal growth, while no significant influence was observed in female newborn piglets. Wang et al. (1995) found that daidzein injected subcutaneously into rats increased male rat growth and was attended by higher growth hormone levels; the results in the female rats were the opposite. (n=16) and control (n=12) groups were normalized with internal standard. Compared with those of the control group, relative IGF-1R mRNA levels in muscle were significantly enhanced (P<0·05), and IGF-1R mRNA levels of thymus and liver were inclined to increase in the daidzein group (P<0·1). No significant changes were detected in hypothalamus or pituitary tissues. However, expression of IGF-1R gene was found to be highest in the hypothalamus and the pituitary, modest in muscle and thymus, and lowest in the liver. Levels are reported as means S.E.M. *P<0·05 vs levels from corresponding control (ANOVA followed by Tukey HSD unequal number multiple comparison test).
Daidzein has demostrated both agonistic and antagonistic effects. At low plasma estrogen levels, daidzein acted agonistically, while at high plasma levels it acted antagonistically (Setchell & Cassidy 1999) . Recently, it was demonstrated that estrogen is important for male animal growth (Vanderschueren et al. 1997 , Sharpe 1998 , Toran-Allerand et al. 1999 . Results from our study and others (Wang et al. 1995 , Liu et al. 1999 show that daidzein may act agonistically in males by promoting fetal growth, while potentially acting antagonistically in female piglets. It is clear that both IGF-I and IGF-II play major roles in controlling the growth of skeletal muscles (Florini et al. 1996) . In vitro (Ewton et al. 1987) and in vivo (Yu & Czech 1984) studies demonstrated that IGF-1R mediates several anabolic actions of IGF-I and IGF-II, including stimulation of amino acid uptake, proliferation and differentiation in skeletal muscle. Results indicate a possible association between higher birth weight and daidzein-enhanced IGF-1R gene expression in skeletal muscle. However, we did not detect ER in newborn piglet muscle. ER but not ER has been proven to mediate effects of estrogen in the skeleton of male mice during growth and maturation (Vidal et al. 2000) . Therefore, it is reasonable to assume that daidzein-influenced muscle IGF-1R gene expression might be effected via ER .
In rat hypothalamus, Pons et al. (1991) found that IGF-1R was highest during the fetal phase and steadily decreased thereafter to low levels in adult rats. Our results support this observation. Results suggest an important role for IGF-I in the growth and differentiation of the brain in the fetus (D'Ercole et al. 1996) , and are consistent with phenomena observed in postnatal brain growth retardation. In breast and uterus tissues, IGF-I and IGF-1R levels were increased by estradiol or combinations of estradiol and progesterone (Clarke et al. 1997) . In rat hypothalamic cell cultures, Pons & Torres-Aleman (1993) found that the addition of 17 -estradiol elicited a significant increase in type-1 IGF receptor protein levels in neurons. In the present study, IGF-1R mRNA levels in the hypothalamus and pituitary were unchanged after daidzein feeding. However, the IGF-1R mRNA levels in skeletal muscle were up-regulated, and the IGF-1R mRNA levels were increased in liver and thymus tissues. These results suggest that estrogen and/or other agonists regulate IGF-1R levels also in a tissue-specific manner and indicate that the IGF system may be a critical regulator of estrogen-mediated growth (Klotz et al. 2000) .
To our knowledge, this is the first study to investigate the distribution of ER in pigs, and is also the first study to provide in vivo evidence that daidzein inhibits ER gene expression in the hypothalamus of pigs. Knowledge about the expression levels of ER in different tissues may be valuable for re-evaluating mechanisms of action for estrogen agonists and antagonists in a tissue-specific manner. Our results suggest that one way daidzein may influence fetal growth is via up-regulation of IGF-1R expression in skeletal muscle. The down-regulation of ER gene expression in the hypothalamus indicates the possible central effects of daidzein on the neuroendocrine system.
